subject: CHEBI:28747

subject_name: Picolinic acid

object_name: atypical depressive disorder


subject: CHEBI:50369

subject_name: Chromium picolinate

tested_intervention: unsure


subject: CHEBI:7726

subject_name: octreotide

object_name: carcinoid syndrome

tested_intervention: yes


subject: UNII:8YHH21923L

object_name: Cannabis use disorder


subject: UNII:8YHH21923L

object_name: Cannabis dependence, continuous


subject: UMLS:C5139947


subject: UMLS:C5139947


subject: UMLS:C0678449

subject_name: Cannabis substance


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: bladder tumor


subject: CHEBI:38290

object_name: urinary bladder carcinoma


subject: CHEBI:38290

object_name: urinary bladder cancer


subject: CHEBI:38290

object_name: childhood bladder carcinoma


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: herpes simplex virus keratitis


subject: PUBCHEM.COMPOUND:89992620

subject_name: AVENCIGUAT

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:89992620

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:ZA7KTB4PSP


subject: UNII:ZA7KTB4PSP


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: Impacted third molar tooth


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: CHEBI:17688

subject_name: Nicotine

object_name: cocaine dependence


subject: UMLS:C3852499

object_name: Familial hypercholesterolemia - heterozygous


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage III Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Breast cancer stage III


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage III Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IB Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135565596

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: malignant neoplasm of breast stage I


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Carcinoma breast stage I


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: malignant neoplasm of breast stage IIb


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IA Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135565596

object_name: stage IA breast cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Multifocal breast carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Postmenopausal


subject: CHEBI:173077

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:173077

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:173077

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:173077

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Breast cancer stage III


subject: CHEBI:173077

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:173077

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:173077

object_name: Breast cancer stage II


subject: CHEBI:173077

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:173077

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: malignant neoplasm of breast stage I


subject: CHEBI:173077

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Carcinoma breast stage I


subject: CHEBI:173077

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:173077

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:173077

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:173077

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:173077

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:173077

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:173077

object_name: stage IA breast cancer


subject: CHEBI:173077

object_name: Multifocal breast carcinoma


subject: CHEBI:173077

object_name: invasive breast carcinoma


subject: CHEBI:173077

object_name: Postmenopausal


subject: CHEBI:6413

subject_name: Letrozole

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:6413

object_name: Breast cancer stage III


subject: CHEBI:6413

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Optic Nerve Injuries


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Huntington disease


subject: CHEBI:39585

subject_name: Carbidopa


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Autoimmunity


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:63450

subject_name: Masitinib

object_name: psoriasis


subject: UNII:879OVM0Y1S

subject_name: Setogepram

object_name: Hyperammonemia


subject: CHEBI:41500

subject_name: Phenylbutyrates


subject: CHEBI:8884

subject_name: Rocuronium

object_name: obstructive sleep apnea syndrome


subject: CHEBI:8772

subject_name: Raloxifene

object_name: endometrial cancer


subject: CHEBI:8772

object_name: uterine corpus cancer


subject: CHEBI:8772

object_name: endometrial carcinoma


subject: GTOPDB:8221

subject_name: epacadostat

object_name: rectal carcinoma


subject: GTOPDB:8221

object_name: rectal cancer


subject: GTOPDB:8221

object_name: Childhood Rectal Carcinoma


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: CHEBI:45783

subject_name: Imatinib

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:45783

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:45783

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:45783

object_name: MALT lymphoma


subject: CHEBI:45783

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:45783

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:45783

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:45783

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:45783

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:45783

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:45783

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:45783

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:45783

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:45783

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:45783

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:45783

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:45783

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:45783

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:45783

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:45783

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:45783

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:45783


subject: CHEBI:45783

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:45783

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:45783

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:45783

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:45783

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:45783

object_name: childhood myelodysplastic syndrome


subject: CHEBI:45783

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:45783

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:45783

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:45783

object_name: anaplastic large cell lymphoma


subject: CHEBI:45783

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:45783

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:45783

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:45783

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:45783

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:45783

object_name: Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive


subject: CHEBI:45783

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:45783

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:45783

object_name: refractory hairy cell leukemia


subject: CHEBI:45783

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:45783

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:45783

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:45783

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:45783

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:45783

object_name: AIDS-related primary central nervous system lymphoma


subject: CHEBI:45783

object_name: solitary osseous plasmacytoma


subject: CHEBI:45783

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:45783

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:45783

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:45783

object_name: splenic marginal zone lymphoma


subject: CHEBI:45783

object_name: chronic neutrophilic leukemia


subject: CHEBI:45783

object_name: AL amyloidosis


subject: CHEBI:45783

object_name: primary systemic amyloidosis


subject: CHEBI:45783

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:45783

object_name: extramedullary plasmacytoma


subject: CHEBI:45783

object_name: prolymphocytic leukemia


subject: CHEBI:45783

object_name: small intestine lymphoma


subject: CHEBI:45783

object_name: intraocular lymphoma


subject: CHEBI:94708

subject_name: Diacerein

object_name: osteoarthritis, hip


subject: UMLS:C0392927

subject_name: T4N5 liposomal lotion

object_name: Recurrent Skin Carcinoma


subject: UMLS:C0392927

object_name: skin basal cell carcinoma


subject: UMLS:C0392927

object_name: skin squamous cell carcinoma


subject: UMLS:C0392927

object_name: actinic keratosis


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Unconjugated hyperbilirubinemia


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5237268

object_name: amyloidosis, hereditary systemic 1


subject: UMLS:C5237268

object_name: classic familial adenomatous polyposis


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: GTOPDB:4934

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib

object_name: cancer


subject: UNII:L4C1UY2NYH

object_name: neoplasm


subject: CHEBI:119486

subject_name: Efavirenz

object_name: prostate carcinoma


subject: CHEBI:119486

object_name: prostate cancer


subject: UMLS:C0964609

object_name: chronic gastritis


subject: UMLS:C0964609

object_name: Acute gastritis


subject: MESH:C000656706

object_name: osteoarthritis, knee


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: metastatic prostate carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C1327972

subject_name: Fowlpox-PSA-TRICOM Vaccine


subject: UMLS:C4282329

subject_name: Prostvac-V


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: Stage II Colorectal Cancer AJCC v7


subject: CHEBI:135915

object_name: Stage II Colorectal Cancer AJCC v6


subject: CHEBI:135915

object_name: Stage III Colorectal Cancer AJCC v6


subject: CHEBI:135915

object_name: Stage III Colorectal Cancer AJCC v7


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Hypotension symptomatic


subject: CHEBI:33569

object_name: Hypovolemic shock


subject: CHEBI:33569

object_name: Hypovolemic


subject: CHEBI:33569

object_name: Hypovolemia


subject: CHEBI:166902

object_name: Shock


subject: CHEBI:166902

object_name: hypotension and shock


subject: CHEBI:166902


subject: CHEBI:166902

object_name: septic shock


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:76842

object_name: Prosthetic joint infection


subject: CHEBI:76842

object_name: Antibiotic resistant infection


subject: CHEBI:76842

object_name: osteoarthritis, hip


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:73678


subject: CHEBI:73678


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: DRUGBANK:DB19252

subject_name: Ecklonia cava

object_name: Hypercholesterolemia


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0919144

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: lung cancer


subject: PUBCHEM.COMPOUND:368860

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:368860

object_name: lung carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Recurrent Salivary Gland Cancer


subject: UNII:PVI5M0M1GW

object_name: untreated metastatic squamous neck cancer with occult primary


subject: UNII:PVI5M0M1GW

object_name: Salivary gland cancer stage IV


subject: UNII:PVI5M0M1GW

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:PVI5M0M1GW

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:PVI5M0M1GW

object_name: Salivary gland cancer stage III


subject: UNII:PVI5M0M1GW

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:PVI5M0M1GW

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:PVI5M0M1GW

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:PVI5M0M1GW

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UNII:PVI5M0M1GW

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UNII:PVI5M0M1GW

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:PVI5M0M1GW

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:PVI5M0M1GW

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:PVI5M0M1GW

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:PVI5M0M1GW

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:PVI5M0M1GW

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UNII:PVI5M0M1GW

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:PVI5M0M1GW

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Stage III Lip Basal Cell Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Lip Basal Cell Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:PVI5M0M1GW

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:PVI5M0M1GW

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UNII:PVI5M0M1GW

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UNII:PVI5M0M1GW

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:PVI5M0M1GW

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Oropharyngeal lymphoepithelioma stage III


subject: UNII:PVI5M0M1GW

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UNII:PVI5M0M1GW

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UNII:PVI5M0M1GW

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:PVI5M0M1GW

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UNII:PVI5M0M1GW

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Laryngeal verrucous carcinoma stage III


subject: UNII:PVI5M0M1GW

object_name: Laryngeal verrucous carcinoma stage IV


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: Recurrent Salivary Gland Cancer


subject: PR:000005932

object_name: untreated metastatic squamous neck cancer with occult primary


subject: PR:000005932

object_name: Salivary gland cancer stage IV


subject: PR:000005932

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: PR:000005932

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: PR:000005932

object_name: Salivary gland cancer stage III


subject: PR:000005932

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: PR:000005932

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: PR:000005932

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: PR:000005932

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: PR:000005932

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PR:000005932

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PR:000005932

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PR:000005932

object_name: Recurrent Lip Basal Cell Carcinoma


subject: PR:000005932

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PR:000005932

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PR:000005932

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PR:000005932

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: PR:000005932

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PR:000005932


subject: PR:000005932

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: PR:000005932

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: PR:000005932

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: PR:000005932

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: PR:000005932

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: PR:000005932

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PR:000005932

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PR:000005932

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: PR:000005932

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: PR:000005932

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PR:000005932

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: PR:000005932

object_name: Stage III Lip Basal Cell Carcinoma


subject: PR:000005932

object_name: Stage IV Lip Basal Cell Carcinoma


subject: PR:000005932

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PR:000005932

object_name: Laryngeal squamous cell carcinoma stage III


subject: PR:000005932

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: PR:000005932

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: PR:000005932

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: PR:000005932

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: PR:000005932

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PR:000005932

object_name: Oropharyngeal lymphoepithelioma stage III


subject: PR:000005932

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: PR:000005932

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: PR:000005932

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: PR:000005932

object_name: Verrucous carcinoma of the oral cavity stage III


subject: PR:000005932

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: PR:000005932

object_name: Laryngeal verrucous carcinoma recurrent


subject: PR:000005932

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: PR:000005932

object_name: Laryngeal verrucous carcinoma stage III


subject: PR:000005932

object_name: Laryngeal verrucous carcinoma stage IV


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: untreated metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:14907381

object_name: Salivary gland cancer stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:14907381

object_name: Salivary gland cancer stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:14907381

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Laryngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Oropharyngeal lymphoepithelioma stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Verrucous carcinoma of the oral cavity stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Laryngeal verrucous carcinoma stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:46345

object_name: Salivary gland cancer stage IV


subject: CHEBI:46345

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:46345

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:46345

object_name: Salivary gland cancer stage III


subject: CHEBI:46345

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:46345

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:46345

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:46345

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:46345

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:46345

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:46345

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:46345


subject: CHEBI:46345

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:46345

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:46345

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:46345

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:46345

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:46345

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:46345

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:46345

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:46345

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:46345

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:46345

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:46345

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:46345

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:46345

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:46345

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:46345

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:46345

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:46345

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:46345

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:46345

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:46345

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:46345

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:46345

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:44423

object_name: Salivary gland cancer stage IV


subject: CHEBI:44423

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:44423

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:44423

object_name: Salivary gland cancer stage III


subject: CHEBI:44423

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:44423

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:44423

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:44423

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:44423

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:44423

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:44423

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:44423


subject: CHEBI:44423

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:44423

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:44423

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:44423

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:44423

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:44423

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:44423

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:44423

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:44423

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:44423

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:44423

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:44423

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:44423

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:44423

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:44423

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:44423

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:44423

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:44423

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:44423

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:44423

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:44423

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:44423

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:44423

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:44423

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:44423

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:44423

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:44423

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:92223

subject_name: Abexinostat

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:92223

object_name: clear cell renal carcinoma


subject: CHEBI:92223

object_name: renal cell adenocarcinoma


subject: CHEBI:92223

object_name: renal cell carcinoma


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: type 1 diabetes mellitus


subject: CHEBI:18167

object_name: hypoglycemia


subject: CHEBI:18167

object_name: Blood glucose below reference range (finding)


subject: CHEBI:18167

object_name: Hypoglycemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEBI:86345

subject_name: magnesium dichloride hexahydrate

object_name: Post-COVID-19 syndrome


subject: CHEBI:86345

object_name: long COVID-19


subject: CHEBI:86345

object_name: vitamin D deficiency


subject: CHEBI:86345

object_name: magnesium deficiency


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C0033681

subject_name: Protein Tyrosine Kinase

object_name: Solid Neoplasm


subject: UMLS:C1524078


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: endometrial hyperplasia without atypia


subject: UNII:RM32SJB09D

object_name: abdominal obesity-metabolic syndrome


subject: UNII:RM32SJB09D

object_name: metabolic syndrome X


subject: UNII:RM32SJB09D

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C1965032

subject_name: calcium butyrate


subject: UMLS:C1965032


subject: UMLS:C1965032


subject: CHEBI:29708

subject_name: Zinc gluconate


subject: CHEBI:29708


subject: CHEBI:29708


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: CHEBI:33198


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: CHEBI:58097

object_name: complex regional pain syndrome


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:31689

subject_name: Iguratimod

object_name: Therapy Object (animal model)


subject: UNII:1C25MR0H0E

object_name: irritable bowel syndrome


subject: CHEBI:4911

subject_name: Etoposide

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: PUBCHEM.COMPOUND:166132569

subject_name: Psilocybin trihydrate

object_name: Psychedelic Experiences


subject: UNII:YG63V98ZDB

subject_name: PSILOCYBIN TRIHYDRATE


subject: UMLS:C4684945

subject_name: Semuloparin Sodium

object_name: cancer


subject: UMLS:C4684945

object_name: neoplasm


subject: UMLS:C5706486

subject_name: BNT 323

object_name: endometrial cancer


subject: UMLS:C5706486

object_name: uterine corpus cancer


subject: UMLS:C5706486

object_name: endometrial carcinoma


subject: CHEBI:29321

subject_name: sodium nitroprusside

object_name: Inflammation


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: PUBCHEM.COMPOUND:129696905


subject: DRUGBANK:DB16576

subject_name: Cardamom

object_name: Xerostomia


subject: DRUGBANK:DB16576

object_name: salivary gland disorder


subject: DRUGBANK:DB16576

object_name: mouth disorder


subject: UMLS:C3887849

subject_name: Cardamom (product)


subject: UMLS:C3887849


subject: UMLS:C3887849


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER


subject: CHEMBL.COMPOUND:CHEMBL2108465


subject: CHEMBL.COMPOUND:CHEMBL2108465


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: uterine fibroid


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: CORONARY ARTERY DISEASE RISK HIGH


subject: CHEBI:41423

subject_name: Celecoxib

object_name: pharyngitis


subject: CHEBI:41423

object_name: Pharyngitis, CTCAE


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage III Gallbladder Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:75179

object_name: stage IVA gallbladder cancer


subject: CHEBI:75179

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: CHEBI:47781

subject_name: Desipramine

object_name: Heartburn


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Childhood Colorectal Carcinoma


subject: MESH:C513941

subject_name: tongxinluo

object_name: coronary microvascular disorder


subject: CHEBI:15927

subject_name: Nicotinamide riboside


subject: UNII:7C9N0VM8NR

object_name: acute lymphoblastic leukemia


subject: UNII:7C9N0VM8NR

object_name: adult lymphoma


subject: UNII:7C9N0VM8NR

object_name: lymphoma


subject: UNII:7C9N0VM8NR

object_name: pediatric lymphoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:36796

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:36796

object_name: Malignant Solid Neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: childhood onset asthma


subject: CHEBI:8888

subject_name: Ropinirole

object_name: bipolar disorder


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: hepatitis C


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: non-24-hour sleep-wake syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C1710381

subject_name: Circadin


subject: UMLS:C1710381

object_name: blindness


subject: CHEBI:78739

subject_name: Emodepside

object_name: onchocerciasis


subject: UMLS:C1098962


subject: CHEBI:15927

object_name: cardiotoxicity


subject: CHEBI:15927

object_name: Childhood Breast Carcinoma


subject: CHEBI:15927

object_name: breast carcinoma


subject: CHEBI:15927

object_name: breast cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: congenital arteriovenous fistula


subject: CHEBI:4466

object_name: Arteriovenous fistula only (in use with two needles)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: MESH:D019444

subject_name: Vaccines, DNA

object_name: Neuroblastoma recurrent


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Chronic Post-Traumatic Stress Disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3077

subject_name: Betamethasone

object_name: pulmonary function measurement


subject: CHEBI:3077

object_name: Functional Residual Capacity


subject: PUBCHEM.COMPOUND:53395955

subject_name: Natrecor

object_name: Heart Failure, CTCAE


subject: UMLS:C1170421


subject: CHEBI:33380

subject_name: thulium atom

object_name: heart failure


subject: CHEBI:33380


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: CHEBI:73558

subject_name: D3 vitamins

object_name: asthma


subject: CHEBI:136044

subject_name: Fimasartan

object_name: Drug Interactions


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: kidney failure


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:47458

object_name: Adult Solid Neoplasm


subject: CHEBI:47458

object_name: Solid Neoplasm


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C0699857

subject_name: Nitrate

object_name: Hypoxemia


subject: UMLS:C0699857

object_name: Hypoxia, CTCAE


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:48107


subject: CHEBI:27732

subject_name: Caffeine

object_name: sleep apnea


subject: CHEBI:27732

object_name: Sleep Apnea, CTCAE


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: UMLS:C4684875

subject_name: Anti-PD-1 Monoclonal Antibody Sym021

object_name: adult lymphoma


subject: UMLS:C4684875

object_name: lymphoma


subject: UMLS:C4684875

object_name: pediatric lymphoma


subject: UMLS:C0078058

subject_name: endothelial growth factor A, vascular

object_name: diabetic neuropathy


subject: UMLS:C1522575

subject_name: Recombinant Vascular Endothelial Growth Factor


subject: UMLS:C1256770

subject_name: Vascular Endothelial Growth Factors


subject: PR:000017284

subject_name: vascular endothelial growth factor A, long form


subject: UNII:84I5UEP321

object_name: Parkinson disease


subject: UMLS:C4053608

subject_name: A2AR Antagonist PBF-509


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: Childhood Breast Carcinoma


subject: CHEBI:77383

object_name: breast carcinoma


subject: CHEBI:77383

object_name: breast cancer


subject: UMLS:C3541401

subject_name: Bisphosphonate drugs affecting bone structure and mineralization


subject: UMLS:C3541401


subject: UMLS:C3541401


subject: MESH:D004164

subject_name: Diphosphonates


subject: MESH:D004164


subject: MESH:D004164


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Adult Myelodysplastic Syndrome


subject: UNII:52CMI0WC3Y

object_name: childhood myelodysplastic syndrome


subject: UNII:52CMI0WC3Y

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:52CMI0WC3Y

object_name: juvenile myelomonocytic leukemia


subject: UNII:52CMI0WC3Y

object_name: chronic myelomonocytic leukemia


subject: UNII:52CMI0WC3Y

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: CHEBI:70839

subject_name: Dasatinib

object_name: embryonal rhabdomyosarcoma


subject: CHEBI:70839

object_name: alveolar rhabdomyosarcoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: Adult Rhabdomyosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: rhabdomyosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: Childhood Rhabdomyosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: CHEBI:50841

subject_name: Loxapine

object_name: Restlessness


subject: CHEBI:50841

object_name: Restlessness, CTCAE


subject: UNII:N94833051K

subject_name: FIBRINOGEN HUMAN

object_name: liver disorder


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C1871272

subject_name: TachoSil


subject: CHEBI:35181

object_name: breast neoplasm


subject: CHEBI:18198

subject_name: 4-amino-4-deoxychorismic acid


subject: CHEBI:157780

subject_name: S-Cysteinosuccinic acid


subject: PR:000022058

subject_name: biodegradative arginine decarboxylase


subject: PR:000007791

subject_name: acidic amino acid decarboxylase GADL1


subject: PR:000023971

subject_name: biosynthetic arginine decarboxylase


subject: UniProtKB:Q7NSA6

subject_name: ADC_CHRVO Acetoacetate decarboxylase (sprot)


subject: PR:000032161

subject_name: antizyme inhibitor 2


subject: UniProtKB:D4A693

subject_name: AZIN2_RAT Antizyme inhibitor 2 (sprot)


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Hypotension during surgery


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Gaucher disease type I


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:93109

subject_name: Semaxanib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:91083

subject_name: Romiplostim


subject: GTOPDB:11592

subject_name: evorpacept

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: UMLS:C4329513


subject: CHEBI:151315

subject_name: Heparin

object_name: Embolism


subject: CHEBI:151315

object_name: Embolus


subject: CHEMBL.COMPOUND:CHEMBL4297724

subject_name: CERTOPARIN


subject: CHEMBL.COMPOUND:CHEMBL4297724


subject: UMLS:C0592534

subject_name: certoparin sodium


subject: UMLS:C0592534


subject: UMLS:C0592532

subject_name: certoparin


subject: UMLS:C0592532


subject: UMLS:C0963149

subject_name: Definity

object_name: Endoleak


subject: CHEBI:31980

subject_name: Perflutren


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: bariatric surgery candidate


subject: UMLS:C1530450

subject_name: AMG 162


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Childhood Breast Carcinoma


subject: MESH:D000086663

object_name: breast carcinoma


subject: MESH:D000086663

object_name: breast cancer


subject: MESH:D000086663

object_name: skin melanoma


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: CHEBI:62088

subject_name: Metamizole

object_name: migraine


subject: CHEBI:5523

subject_name: Goserelin

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:5523

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473

object_name: HER2 positive breast carcinoma


subject: UMLS:C0149473


subject: UMLS:C0780194

subject_name: L-Arginine powder

object_name: Diabetic foot ulcer


subject: UMLS:C0780194

object_name: Diabetic peripheral neuropathy


subject: UMLS:C0780194

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UNII:F925RR824R

subject_name: Tecovirimat

object_name: Orthopox virus infection


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: smoldering plasma cell myeloma


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:6504

object_name: acute kidney failure


subject: CHEBI:6504

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: Clostridium difficile colitis


subject: CHEBI:73788

object_name: clostridium difficile infection


subject: UMLS:C4725692

subject_name: East Indian Sandalwood Oil Cream

object_name: Condylomata acuminata in women


subject: UMLS:C4725692

object_name: Genital warts


subject: UMLS:C4725692

object_name: Condylomata acuminata in men


subject: UNII:37NT056AT4

subject_name: Remetinostat

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C4722476


subject: UMLS:C4722476

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:94705

object_name: Fungal resistance


subject: CHEBI:9448

subject_name: Terbinafine


subject: UNII:IL870Q3Z8I

subject_name: Cobiprostone

object_name: Oral Mucositis


subject: UNII:IL870Q3Z8I

object_name: stomatitis


subject: UNII:IL870Q3Z8I

object_name: oral mucositis


subject: UNII:23Y0B94E49

object_name: Disseminated Malignant Neoplasm


subject: UNII:23Y0B94E49

object_name: Embolism, Tumor


subject: UNII:23Y0B94E49

object_name: Neoplasm Metastasis


subject: UNII:23Y0B94E49

object_name: prostate carcinoma


subject: UNII:23Y0B94E49

object_name: prostate cancer


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: CHEBI:31709

subject_name: Iohexol

object_name: Shock


subject: CHEBI:31621

subject_name: Flunarizine hydrochloride

object_name: juvenile absence epilepsy


subject: CHEBI:31621

object_name: childhood absence epilepsy


subject: CHEBI:31621

object_name: juvenile myoclonic epilepsy


subject: CHEBI:135652

subject_name: Flunarizine


subject: CHEBI:135652


subject: CHEBI:135652


subject: CHEBI:6339

subject_name: Etoricoxib


subject: CHEBI:6339


subject: CHEBI:204734

subject_name: Desonide

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:46874763

object_name: plasma cell myeloma


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:75722

subject_name: Tramadol

object_name: Surgical wound


subject: CHEBI:75722

object_name: Surgical wound finding


subject: CHEBI:75722

object_name: orthopedic disorders of spine


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate

object_name: Pregnancy Outcome


subject: CHEBI:34954

object_name: Labor Pain


subject: CHEBI:34954

object_name: mental disorder


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:9316


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: lupus nephritis


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:68646

object_name: acute myeloid leukemia


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UMLS:C3853898

object_name: Solid Neoplasm


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: viral disease


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Drug action (disorder)


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: liver disorder


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: Coronary artery disease (CAD) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ASHD))


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Neonatal circulatory failure


subject: UMLS:C2000258

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C2000258

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: HIV infection


subject: UMLS:C2934919

object_name: acute coronary syndrome


subject: UMLS:C2934919

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: cystic fibrosis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: malignant neoplasm of breast stage I


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Inflammation


subject: CHEBI:16480

object_name: Platelet dysfunction


subject: CHEBI:31348

subject_name: Capecitabine

object_name: clear cell adenocarcinoma


subject: UNII:Q46947FE7K

object_name: acute hepatitis C virus infection


subject: UNII:M310323W0U

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: melanoma


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: Estrogen Receptor Positive


subject: CHEBI:231356

subject_name: Varlitinib

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Metastasis


subject: PUBCHEM.COMPOUND:21879648

object_name: Metastatic Lesion


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Embolism, Tumor


subject: CHEBI:63584

object_name: Neoplasm Metastasis


subject: CHEBI:63584


subject: CHEBI:63584


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: PUBCHEM.COMPOUND:70691416

subject_name: ISEGANAN HYDROCHLORIDE

object_name: pneumonia


subject: PUBCHEM.COMPOUND:70691416

object_name: COVID-19-Associated Pneumonia


subject: UNII:1AAO72P26F


subject: UNII:1AAO72P26F


subject: UMLS:C1134510

subject_name: Iseganan Hydrochloride


subject: UMLS:C1134510


subject: PUBCHEM.COMPOUND:124389175

object_name: pituitary gland disorder


subject: PUBCHEM.COMPOUND:124389175

object_name: thyroid disease


subject: PUBCHEM.COMPOUND:124389175

object_name: reported prior thyroid disease (history)


subject: CHEBI:35940

subject_name: Protirelin


subject: CHEBI:35940


subject: CHEBI:35940


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Urinary incontinence


subject: CHEBI:16958

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:16958

object_name: prostate carcinoma


subject: CHEBI:16958

object_name: prostate cancer


subject: UMLS:C0000392

subject_name: beta-alanine


subject: UMLS:C0000392


subject: UMLS:C0000392


subject: UMLS:C0000392


subject: CHEBI:4026

object_name: mediastinal malignant lymphoma


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: primary central nervous system lymphoma


subject: CHEBI:5864


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C0687700

subject_name: CCNU


subject: UMLS:C0687700

object_name: Burkitt lymphoma


subject: UMLS:C0687700

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C0687700

object_name: Adult Burkitt Lymphoma


subject: UMLS:C0687700


subject: UMLS:C0687700

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0687700

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C0687700

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Femoroacetabular impingement


subject: CHEBI:28918

object_name: Acetabular labrum tear


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:3757

object_name: Hip dysplasia


subject: CHEBI:3757

object_name: Hip Dysplasia


subject: UNII:4YK5Z54AT2

subject_name: [OBSOLETE] denatonium benzoate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:4YK5Z54AT2

object_name: obesity


subject: UNII:4YK5Z54AT2

object_name: Obesity, CTCAE


subject: CHEBI:232400

subject_name: denatonium benzoate


subject: CHEBI:232400


subject: CHEBI:232400


subject: CHEBI:156287

subject_name: Pidnarulex

object_name: cancer


subject: CHEBI:156287

object_name: neoplasm


subject: UMLS:C3896901

object_name: skin neoplasm


subject: UMLS:C0733521

subject_name: Ara-C

object_name: plasma cell myeloma


subject: UMLS:C4307370


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:32150

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:32150

object_name: Locally Advanced Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:32150

object_name: Locally Advanced Laryngeal Squamous Cell Carcinoma


subject: CHEBI:32150

object_name: Locally Advanced Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:32150

object_name: Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:32150

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:32150

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:32150

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:32150

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:132112

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:132112

object_name: Locally Advanced Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:132112

object_name: Locally Advanced Laryngeal Squamous Cell Carcinoma


subject: CHEBI:132112

object_name: Locally Advanced Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:132112

object_name: Locally Advanced Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:132112

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:132112

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:132112

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Collagen fibril alteration


subject: GTOPDB:13084

subject_name: narlumosbart

object_name: bone disorder


subject: GTOPDB:13084

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL5314993

subject_name: NARLUMOSBART


subject: CHEMBL.COMPOUND:CHEMBL5314993


subject: UMLS:C5783725

subject_name: Narlumosbart


subject: UMLS:C5783725


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: postmenopausal osteoporosis


subject: UNII:RUU8G67GQM

subject_name: Escin

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:4555259

subject_name: Aescin


subject: CHEBI:26605

subject_name: saponin


subject: CHEBI:2500

subject_name: beta-Escin


subject: UMLS:C5235868

object_name: skin squamous cell carcinoma


subject: UMLS:C5235868

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C2981820

object_name: Carcinoma breast stage IV


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Pregnant


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: prostate carcinoma


subject: CHEBI:71956

object_name: prostate cancer


subject: CHEBI:71956

object_name: prostate neoplasm


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UMLS:C5446595

subject_name: Zirconium Zr 89-DFO-fianlimab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5446595

object_name: large B-cell lymphoma


subject: CHEBI:16302

object_name: graft versus host disease


subject: CHEBI:16302

object_name: vitamin D deficiency


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: CHEBI:32162

subject_name: sulfalene

object_name: Schistosoma mansoni infectious disease


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: UMLS:C1327799

subject_name: Autologous Dendritic Cell-Adenovirus P53 Vaccine

object_name: lung cancer


subject: UMLS:C1327799

object_name: lung neoplasm


subject: UMLS:C1327799

object_name: lung carcinoma


subject: CHEBI:71957

object_name: ovarian cancer


subject: CHEBI:71957

object_name: ovarian carcinoma


subject: CHEBI:71957

object_name: malignant epithelial tumor of ovary


subject: UNII:60ES45KTMK

subject_name: Pilaralisib


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: PUBCHEM.COMPOUND:21583979

subject_name: Saccharin sodium

object_name: type 2 diabetes mellitus


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Overweight and obesity


subject: CHEBI:25681

object_name: Essential fatty acid deficiency


subject: CHEBI:25681

object_name: Lifestyle-related condition


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: diarrhea


subject: CHEBI:63584

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:63584

object_name: Diarrhea, CTCAE


subject: CHEBI:63584

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:63584

object_name: Prostate cancer stage I


subject: CHEBI:63584

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:63584

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:63584

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:63584

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:63584

object_name: Carcinoma of the prostate stage III


subject: CHEBI:63584

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:63584

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:63584

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:63584

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:63584

object_name: Stage IIA Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: hormone-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:6917964

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: PUBCHEM.COMPOUND:6917964


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:7726

object_name: Prostate cancer stage I


subject: CHEBI:7726

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:7726

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:7726

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:7726

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:7726

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:7726

object_name: Carcinoma of the prostate stage III


subject: CHEBI:7726

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:7726

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:7726

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:7726

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:7726

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UNII:MWH8YQ1AIO

subject_name: OCTREOTIDE PAMOATE

object_name: diarrhea


subject: UNII:MWH8YQ1AIO

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:MWH8YQ1AIO

object_name: Diarrhea, CTCAE


subject: UNII:MWH8YQ1AIO

object_name: hormone-resistant prostate carcinoma


subject: UNII:MWH8YQ1AIO

object_name: Prostate cancer recurrent


subject: UNII:MWH8YQ1AIO

object_name: Stage I Prostate Cancer AJCC v6


subject: UNII:MWH8YQ1AIO

object_name: Prostate cancer stage I


subject: UNII:MWH8YQ1AIO

object_name: Stage I Prostate Cancer AJCC v8


subject: UNII:MWH8YQ1AIO

object_name: Stage I Prostate Cancer AJCC v7


subject: UNII:MWH8YQ1AIO

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:MWH8YQ1AIO

object_name: Carcinoma of the prostate stage IV


subject: UNII:MWH8YQ1AIO

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:MWH8YQ1AIO

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:MWH8YQ1AIO

object_name: Stage III Prostate Cancer AJCC v8


subject: UNII:MWH8YQ1AIO

object_name: Stage III Prostate Cancer AJCC v7


subject: UNII:MWH8YQ1AIO

object_name: Carcinoma of the prostate stage III


subject: UNII:MWH8YQ1AIO

object_name: Stage III Prostate Cancer AJCC v6


subject: UNII:MWH8YQ1AIO

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UNII:MWH8YQ1AIO

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UNII:MWH8YQ1AIO

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UNII:MWH8YQ1AIO

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C0338271

object_name: diarrhea


subject: UMLS:C0338271

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C0338271

object_name: Diarrhea, CTCAE


subject: UMLS:C0338271

object_name: hormone-resistant prostate carcinoma


subject: UMLS:C0338271

object_name: Prostate cancer recurrent


subject: UMLS:C0338271

object_name: Stage I Prostate Cancer AJCC v6


subject: UMLS:C0338271

object_name: Prostate cancer stage I


subject: UMLS:C0338271

object_name: Stage I Prostate Cancer AJCC v8


subject: UMLS:C0338271

object_name: Stage I Prostate Cancer AJCC v7


subject: UMLS:C0338271

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C0338271

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C0338271

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C0338271

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C0338271

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C0338271

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C0338271

object_name: Carcinoma of the prostate stage III


subject: UMLS:C0338271

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C0338271

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C0338271

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C0338271

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C0338271

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:8382

subject_name: Prednisone

object_name: diarrhea


subject: CHEBI:8382

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:8382

object_name: Diarrhea, CTCAE


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:67357

subject_name: Dolastatin 10

object_name: adult lymphoma


subject: CHEBI:67357

object_name: lymphoma


subject: CHEBI:67357

object_name: pediatric lymphoma


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C5709274

subject_name: Yisaipu

object_name: ankylosing spondylitis


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: Childhood Solid Neoplasm


subject: UMLS:C0935868

object_name: Adult Solid Neoplasm


subject: UMLS:C0935868

object_name: Solid Neoplasm


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: dyspepsia


subject: UNII:L500PR95QA

object_name: Dyspepsia, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: QT INTERVAL, VARIATION IN


subject: CHEBI:24433

subject_name: group


subject: CHEBI:4856

subject_name: Esmolol

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:18319735

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Vascular Stiffness


subject: KEGG.COMPOUND:C00816

subject_name: Collagenase

object_name: Traumatic Wound


subject: UNII:9X7O8V25IT

subject_name: collagenase


subject: CHEBI:4445

subject_name: Desflurane

object_name: ureterostomy; functional disturbance


subject: CHEBI:4445

object_name: Ureteral stent occlusion


subject: CHEBI:4445

object_name: Excessive repair


subject: CHEBI:4445

object_name: Exposure to lasers


subject: CHEBI:4445

object_name: Bladder Injury


subject: CHEBI:4445

object_name: vaginal disease


subject: CHEBI:4445

object_name: Calculi


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: High Risk Myelodysplastic Syndrome


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Refractory acute myeloid leukemia


subject: UNII:3A58010674

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:3A58010674


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C5962079

subject_name: Anti-ILT2/Anti-ILT4 Bispecific Antibody PF-07826390

object_name: colorectal carcinoma


subject: UMLS:C5962079

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5962079

object_name: clear cell renal carcinoma


subject: UMLS:C5962079

object_name: renal cell adenocarcinoma


subject: UMLS:C5962079

object_name: renal cell carcinoma


subject: UMLS:C5962079

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5962079

object_name: ovarian cancer


subject: UMLS:C5962079

object_name: ovarian carcinoma


subject: UMLS:C5962079

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5962079

object_name: neoplasm


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C3827082


subject: CHEBI:32599

object_name: COPD exacerbation


subject: UMLS:C2715577

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C2715577

object_name: acute lymphoblastic leukemia


subject: UMLS:C2715577

object_name: Myelodysplasia


subject: UMLS:C2715577

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C2715577

object_name: childhood myelodysplastic syndrome


subject: UMLS:C2715577

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2715577

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2715577

object_name: acute myeloid leukemia


subject: UNII:49X2Q41T99

subject_name: PEGSITACIANINE

object_name: lung cancer


subject: UNII:49X2Q41T99

object_name: lung neoplasm


subject: UNII:49X2Q41T99

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin

object_name: ovarian reserve


subject: UMLS:C0025326

subject_name: Menotropins


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:6438809

subject_name: Deanxit

object_name: coronary microvascular disorder


subject: UMLS:C0057220


subject: CHEBI:5119

subject_name: fluoxetine hydrochloride


subject: CHEBI:5118

subject_name: Fluoxetine


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IV Colorectal Cancer AJCC v6


subject: UNII:28X28X9OKV

object_name: PMS2 mutation


subject: UNII:28X28X9OKV

object_name: MSH6 mutation


subject: UNII:28X28X9OKV

object_name: MLH1 Gene Mutation


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:03B2YGW6PL

subject_name: FIBROBLAST GROWTH FACTOR 5

object_name: renal carcinoma


subject: UNII:03B2YGW6PL

object_name: kidney neoplasm


subject: UNII:03B2YGW6PL

object_name: kidney cancer


subject: GTOPDB:4926


subject: GTOPDB:4926


subject: GTOPDB:4926


subject: PR:000007496

subject_name: fibroblast growth factor 5


subject: PR:000007496


subject: PR:000007496


subject: UMLS:C4279258

object_name: Recurrent ovarian cancer


subject: UMLS:C4279258

object_name: colorectal carcinoma


subject: UMLS:C4279258

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:6335487

object_name: Metabolic acidosis, normal anion gap (NAG)


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: DRUGBANK:DB15654

subject_name: Moderna COVID-19 Vaccine

object_name: Immunocompromised Host


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273


subject: CHEBI:29235

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:18276

subject_name: Hydrogen


subject: UMLS:C0885426

subject_name: Hydrogen, Homeopathic preparation


subject: CHEMBL.COMPOUND:CHEMBL4297766

subject_name: HYDROGEN


subject: UNII:PF9462I9HX

subject_name: Larotrectinib

object_name: thyroid tumor


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Congenital IGHD


subject: CHEBI:84094

object_name: Reduced circulating growth hormone concentration


subject: CHEBI:84094

object_name: hypopituitarism


subject: CHEBI:84094

object_name: Hypopituitarism, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: hypogonadism


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2355616

subject_name: highly purified urofollitropin

object_name: anovulation


subject: UMLS:C2355616

object_name: Female infertility associated with anovulation


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: cancer


subject: CHEBI:28911

object_name: neoplasm


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: epidermolysis bullosa


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Arrhythmia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: inherited epidermolysis bullosa


subject: MESH:C573452

subject_name: Embryo glue

object_name: infertility


subject: UMLS:C4554271

subject_name: PROTHROMBIN TIME

object_name: hemorrhagic disease


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Birthing Labor


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:31355

subject_name: Carboplatin


subject: DRUGBANK:DB10629

subject_name: Blueberry

object_name: Inflammatory Response


subject: DRUGBANK:DB10629

object_name: metabolic disturbance


subject: DRUGBANK:DB10629

object_name: IMMUNE SUPPRESSION


subject: DRUGBANK:DB10629

object_name: Decreased Immunologic Activity [PE]


subject: MESH:C000721609

subject_name: blueberry extract


subject: MESH:C000721609


subject: MESH:C000721609


subject: MESH:C000721609


subject: UMLS:C0939797

subject_name: banana extract


subject: UMLS:C0939797


subject: UMLS:C0939797


subject: UMLS:C0939797


subject: DRUGBANK:DB10505

subject_name: Banana


subject: DRUGBANK:DB10505


subject: DRUGBANK:DB10505


subject: DRUGBANK:DB10505


subject: CHEBI:6532

subject_name: Loperamide

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:31498

subject_name: Simethicone


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Estrogen Receptor Positive


subject: CHEBI:175901

object_name: HER2/Neu Negative


subject: CHEBI:175901

object_name: invasive breast carcinoma


subject: CHEBI:175901

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: MESH:C000629782

subject_name: talimogene laherparepvec


subject: MESH:C000629782

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: MESH:C000629782


subject: MESH:C000629782

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C0529792

object_name: tinea unguium


subject: PUBCHEM.COMPOUND:53716604

subject_name: Fluorodeoxyglucose

object_name: histiocytosis


subject: PUBCHEM.COMPOUND:53716604

object_name: Histiocytic syndrome


subject: UMLS:C4553797


subject: UMLS:C4553797


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:23359

subject_name: colchicine

object_name: hypertension


subject: CHEBI:23359

object_name: Hypertension, CTCAE


subject: CHEBI:75998

subject_name: Trametinib

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:75998

object_name: Metastatic Colon Carcinoma


subject: CHEBI:75998

object_name: Metastatic Rectal Carcinoma


subject: CHEBI:75998

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage III Colorectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:75998

object_name: RAS Family Gene Mutation


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Metastatic Colon Carcinoma


subject: CHEBI:75179

object_name: Metastatic Rectal Carcinoma


subject: CHEBI:75179

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: CHEBI:75179


subject: CHEBI:75179

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:229469

subject_name: Sulodexide

object_name: Tinnitus, Subjective


subject: UMLS:C0354566

subject_name: intravenous heparin

object_name: anaphylaxis


subject: UMLS:C0354566

object_name: Anaphylaxis;non medication


subject: UMLS:C0354566

object_name: Anaphylaxis, CTCAE


subject: UMLS:C0243071

subject_name: Analog

object_name: type 2 diabetes mellitus


subject: CHEBI:44658

subject_name: okadaic acid

object_name: herpes zoster